TR201914043A1 - Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari - Google Patents
Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlariInfo
- Publication number
- TR201914043A1 TR201914043A1 TR2019/14043A TR201914043A TR201914043A1 TR 201914043 A1 TR201914043 A1 TR 201914043A1 TR 2019/14043 A TR2019/14043 A TR 2019/14043A TR 201914043 A TR201914043 A TR 201914043A TR 201914043 A1 TR201914043 A1 TR 201914043A1
- Authority
- TR
- Turkey
- Prior art keywords
- metformin
- efervesan
- dapaglyflozin
- tablet formulations
- formulations containing
- Prior art date
Links
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 title abstract 3
- 229960003105 metformin Drugs 0.000 title abstract 3
- 239000007916 tablet composition Substances 0.000 title 1
- JVHXJTBJCFBINQ-ADAARDCZSA-N Dapagliflozin Chemical compound C1=CC(OCC)=CC=C1CC1=CC([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=CC=C1Cl JVHXJTBJCFBINQ-ADAARDCZSA-N 0.000 abstract 2
- 229960003834 dapagliflozin Drugs 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000007938 effervescent tablet Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2019/14043A TR201914043A1 (tr) | 2019-09-16 | 2019-09-16 | Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari |
| PCT/TR2020/050687 WO2021054912A1 (fr) | 2019-09-16 | 2020-08-05 | Formulations de comprimés effervescents comprenant de la dapagliflozine et de la metformine |
| EP20866500.0A EP4031122A4 (fr) | 2019-09-16 | 2020-08-05 | Formulations de comprimés effervescents comprenant de la dapagliflozine et de la metformine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2019/14043A TR201914043A1 (tr) | 2019-09-16 | 2019-09-16 | Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201914043A1 true TR201914043A1 (tr) | 2021-04-21 |
Family
ID=74883168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/14043A TR201914043A1 (tr) | 2019-09-16 | 2019-09-16 | Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4031122A4 (fr) |
| TR (1) | TR201914043A1 (fr) |
| WO (1) | WO2021054912A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4079296A1 (fr) * | 2021-04-21 | 2022-10-26 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Formulation de comprimé bicouche comprenant de la dapagliflozine amorphe et de la metformine |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1945190A1 (fr) * | 2005-09-22 | 2008-07-23 | Swissco Devcelopment AG | Composition effervescente de metformine et comprimés et granules fabriqués à partir de cette composition |
| JP5775522B2 (ja) | 2009-11-13 | 2015-09-09 | アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ | 二層錠製剤 |
| EP2809311A1 (fr) * | 2012-01-31 | 2014-12-10 | Mahmut Bilgic | Formulations de comprimés effervescents contenant la combinaison voglibose et metformine |
| WO2017098481A1 (fr) * | 2015-12-12 | 2017-06-15 | Steerlife India Private Limited | Compositions effervescentes de metformine et leurs procédés de préparation |
| WO2018185669A1 (fr) | 2017-04-07 | 2018-10-11 | Zenvision Pharma Llp | Compositions effervescentes comprenant de la saxagliptine ou un sel de celle-ci |
-
2019
- 2019-09-16 TR TR2019/14043A patent/TR201914043A1/tr unknown
-
2020
- 2020-08-05 EP EP20866500.0A patent/EP4031122A4/fr active Pending
- 2020-08-05 WO PCT/TR2020/050687 patent/WO2021054912A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021054912A1 (fr) | 2021-03-25 |
| EP4031122A1 (fr) | 2022-07-27 |
| EP4031122A4 (fr) | 2023-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201916829A2 (tr) | Dapagli̇flozi̇n ve metformi̇n i̇çeren çi̇ft katmanli tablet formülasyonlari | |
| JOP20220008A1 (ar) | مثبطات parp1 | |
| DOP2020000102A (es) | Compuestos útiles para inhibir a cdk7 | |
| PH12018500047B1 (en) | Notch pathway signaling inhibitor compounds | |
| PH12019550249A1 (en) | Solid compositions for oral administration | |
| MX2017016802A (es) | Formulaciones farmaceuticas. | |
| MX2020005483A (es) | Antagonistas de ildr2 y combinaciones de los mismos. | |
| MX2020010697A (es) | Kit, composicion y terapia de combinacion para el sindrome del cromosoma x fragil. | |
| ZA202006377B (en) | Boronic acid derivatives and therapeutic uses thereof | |
| EA202090542A1 (ru) | Высококонцентрированные лекарственные формы придопидина | |
| CL2020002199A1 (es) | Compuesto de anillo de metillactama y uso farmacéutico del mismo. | |
| TR201914043A1 (tr) | Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari | |
| GEP20237486B (en) | Formulations of copanlisib | |
| PH12018501758A1 (en) | Oritavancin formulations | |
| PH12020551985A1 (en) | Anti-human tlr7 antibody | |
| TR201913472A2 (tr) | Vi̇ldagli̇pti̇n ve metformi̇n i̇çeren bi̇r kombi̇nasyon | |
| MX2021003830A (es) | Uso terapéutico del glucagón y combinación que incluye el mismo. | |
| TR201722367A2 (tr) | Lakozami̇d i̇çeren parenteral uygulmaya yöneli̇k farmasöti̇k kompozi̇syonlar | |
| TR201713954A2 (tr) | Tenofovir, emtrisitabin ve efavirenzin farmasötik kombinasyonlari | |
| BR112022012584A2 (pt) | Compostos e derivados de hidroxiestilbeno substituído, síntese e uso deles | |
| EA201691422A1 (ru) | Перорально распадающиеся таблетированные составы мемантина | |
| TR201914416A1 (tr) | Sapropteri̇n di̇hi̇droklorürün efervesan formülasyonlari | |
| TR201721824A2 (tr) | Li̇nagli̇pti̇n ve metformi̇n i̇çeren modi̇fi̇ye salim sağlayan kombi̇nasyon | |
| TR201914420A2 (tr) | Sapropteri̇n di̇hi̇droklorür ve en az bi̇r anti̇oksi̇dan i̇çeren farmasöti̇k formülasyonlar | |
| TR201914034A2 (tr) | Schi̇sandri̇n b etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi |